Six cases of primary colorectal cancer after living-donor liver transplantation: A single-institution experience in japan

Japanese Journal of Clinical Oncology

Volumn 42, Issue 7, 2012, Pages 586-590

  Kazama, Shinsuke ^a   Hongo, Kumiko ^a   Sunami, Eiji ^a   Sugawara, Yasuhiko ^b   Kokudo, Norihiro ^b   Kitayama, Joji ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Colorectal cancer; Immunosuppression; Living donor liver transplantation; Primary sclerosing cholangitis

Indexed keywords

ADULT; AGED; ARTICLE; BILE DUCT ATRESIA; BILIARY CIRRHOSIS; CANCER GROWTH; CANCER INVASION; CANCER SURGERY; CLINICAL ARTICLE; COLORECTAL CANCER; ENDOSCOPIC SURGERY; FEMALE; HEPATITIS; HUMAN; JAPAN; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; LIVING DONOR; MALE; MEDICAL RECORD REVIEW; PERITONEUM METASTASIS; POSTOPERATIVE COMPLICATION; PRIMARY TUMOR; RETROSPECTIVE STUDY; SURGICAL PATIENT;

ADULT; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; JAPAN; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MEDICAL RECORDS; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84864350806     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hys073     Document Type: Article

References (37)

1. Delco F, Mullhaupt B. Should we screen for colorectal cancer in liver transplantation? J Hepatol 2006;44:32-8.
2. Murray JE, Wilson RE, Tilney NL, et al. Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula. Ann Surg 1968;168:416-35.
3. Penn I, Hammond W, Brettschneider L, Starzl TE. Malignant lymphomas in transplantation patients. Transplant Proc 1969;1:106-12.
4. Penn I, Starzl TE. Malignant tumors arising de novo in immunosuppressed organ transplant recipients. Transplantation 1972;14:407-17.
5. Duvoux C, Delacroix I, Richardet JP, et al. Increased incidence of oropharyngeal squamous cell carcinomas after liver transplantation for alcoholic cirrhosis. Transplantation 1999;67:418-21.
6. Haagsma EB, Hagens VE, Schaapveld M, et al. Increased cancer risk after liver transplantation: a population-based study. J Hepatol 2001;34:84-91.
7. Xiol X, Guardiola J, Menendez S, et al. Risk factors for development of de novo neoplasia after liver transplantation. Liver Transpl 2001;7:971-5.
8. Sanchez EQ, Marubashi S, Jung G, et al. De novo tumors after liver transplantation: a single-institution experience. Liver Transpl 2002;8:285-91.
9. Oo YH, Gunson BK, Lancashire RJ, Cheng KK, Neuberger JM. Incidence of cancers following orthotopic liver transplantation in a single center: comparison with national cancer incidence rates for England and Wales. Transplantation 2005;80:759-64.
10. Aseni P, Vertemati M, De Carlis L, et al. De novo cancers and post-transplant lymphoproliferative disorder in adult liver transplantation. Pathol Int 2006;56:712-5.
11. Herrero JI, Alegre F, Quiroga J, et al. Usefulness of a program of neoplasia surveillance in liver transplantation. A preliminary report. Clin Transplant 2009;23:532-6.
12. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010;46:765-81.
13. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277-300.
14. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T. Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 2011;41:139-47.
15. Catena F, Nardo B, Liviano d'Arcangelo G, et al. De novo malignancies after organ transplantation. Transplant Proc 2001;33:1858-9.
16. Vera A, Gunson BK, Ussatoff V, et al. Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. Transplantation 2003;75:1983-8.
17. Silva MA, Jambulingam PS, Mirza DF. Colorectal cancer after orthotopic liver transplantation. Crit Rev Oncol Hematol 2005;56:147-53.
18. Frezza EE, Fung JJ, van Thiel DH. Non-lymphoid cancer after liver transplantation. Hepatogastroenterology 1997;44:1172-81.
19. Kelly DM, Emre S, Guy SR, Miller CM, Schwartz ME, Sheiner PA. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors. Cancer 1998;83:1237-43.
20. Jain AB, Yee LD, Nalesnik MA, et al. Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. Transplantation 1998;66:1193-200.
21. Fabia R, Levy MF, Testa G, et al. Colon carcinoma in patients undergoing liver transplantation. Am J Surg 1998;176:265-9.
22. Penn I. Cancer in the immunosuppressed organ recipient. Transplant Proc 1991;23:1771-2.
23. Aberg F, Pukkala E, Hockerstedt K, Sankila R, Isoniemi H. Risk of malignant neoplasms after liver transplantation: a population-based study. Liver Transpl 2008;14:1428-36.
24. Sint Nicolaas J, de Jonge V, Steyerberg EW, Kuipers EJ, van Leerdam ME, Veldhuyzen-van Zanten SJ. Risk of colorectal carcinoma in post-liver transplant patients: a systematic review and meta-analysis. Am J Transplant 2010;10:868-76.
25. Higashi H, Yanaga K, Marsh JW, Tzakis A, Kakizoe S, Starzl TE. Development of colon cancer after liver transplantation for primary sclerosing cholangitis associated with ulcerative colitis. Hepatology 1990;11:477-80.
26. Knechtle SJ, D'Alessandro AM, Harms BA, Pirsch JD, Belzer FO, Kalayoglu M. Relationships between sclerosing cholangitis, inflammatory bowel disease, and cancer in patients undergoing liver transplantation. Surgery 1995;118:615-9; discussion 9-20.
27. Loftus EV, Jr, Aguilar HI, Sandborn WJ, et al. Risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis following orthotopic liver transplantation. Hepatology 1998;27:685-90.
28. Hanouneh IA, Macaron C, Lopez R, Zein NN, Lashner BA. Risk of colonic neoplasia after liver transplantation for primary sclerosing cholangitis. Inflamm Bowel Dis 2012;18:269-74.
29. Takikawa H, Manabe T. Primary sclerosing cholangitis in Japan- analysis of 192 cases. J Gastroenterol 1997;32:134-7.
30. Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990;323:1228-33.
31. Takikawa H. Characteristics of primary sclerosing cholangitis in Japan. Hepatol Res 2007;37:S470-3.
32. Buell JF, Papaconstantinou HT, Skalow B, Hanaway MJ, Alloway RR, Woodle ES. De novo colorectal cancer: five-year survival is markedly lower in transplant recipients compared with the general population. Transplant Proc 2005;37:960-1.
33. Tabata N, Ohno Y, Matsui R, et al. Partial cancer prevalence in Japan up to 2020: estimates based on incidence and survival data from population-based cancer registries. Jpn J Clin Oncol 2008;38:146-57.
34. Johnson EE, Leverson GE, Pirsch JD, Heise CP. A 30-year analysis of colorectal adenocarcinoma in transplant recipients and proposal for altered screening. J Gastrointest Surg 2007;11:272-9.
35. Goss JA, Shackleton CR, Farmer DG, et al. Orthotopic liver transplantation for primary sclerosing cholangitis. A 12-year single center experience. Ann Surg 1997;225:472-81; discussion 81-3.
36. Watanabe T, Itabashi M, Shimada Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol 2012;17:1-29.
37. Sato T, Ueno H, Mochizuki H, et al. Objective criteria for the grading of venous invasion in colorectal cancer. Am J Surg Pathol 2010;34:454-62.